newsfilter
← Latest News
GlobeNewswire·

Novo Nordisk has completed its acquisition of Akero Therapeutics

Bagsværd, Denmark and South San Francisco, CA, US, 9 December 2025 – Novo Nordisk and Akero Therapeutics Inc. ("Akero") (NASDAQ:AKRO) today announced that Novo Nordisk's acquisition of Akero, announced on 9 October 2025,